Why the study?
LQT1 arises from KCNQ1 mutations causing diminished IKs and proarrhythmic symptoms, creating a need for patient-derived models to support translational research.
The successful derivation of an iPSC line from an LQT1 patient with a specific KCNQ1 variant provides a valuable model for translational research in proarrhythmic conditions.
Should not change LQT1 clinical practice; leaves open iPSC-based studies of seizure-linked arrhythmogenesis.
Long QT syndrome type 1 (LQT1) arises from mutations in the KCNQ1 gene that diminish the slow delayed rectifier potassium current (I Ks ), leading to a prolonged action potential duration in cardiomyocytes and a prolonged QT interval clinically. LQT1 patients can develop proarrhythmic symptoms that can manifest as seizures, syncope, cardiac arrest, or sudden death. An iPSC line was derived from an LQT1 patient with clinically documented seizures carrying the pathogenic KCNQ1 c.1552C > T (p.Arg518Ter) variant; the line exhibits a normal karyotype, pluripotency, trilineage differentiation capacity, and typical stem cell morphology, supporting LQT1-related studies across translational research domains
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: